Breaking News, Collaborations & Alliances

UCB, biOasis In Research Pact

To use Transcend technology for drug delivery to the brain

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

biOasis Technologies and UCB, based in Brussels, have entered into a research collaboration to evaluate biOasis’ Transcend technology for the delivery of therapeutic compounds to the brain. biOasis will conduct certain experiments using its Transcend technology as it relates to the delivery of therapeutic compounds owned by UCB for CNS disorders. Financial Terms were not disclosed.   “UCB is a highly respected biopharmaceutical company with a broad global presence and a deep pipeline. We’r...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters